Boosting 5-ALA-based photodynamic therapy by a liposomal nanomedicine through intracellular iron ion regulation
5-Aminolevulinic acid (5-ALA) has been approved for clinical photodynamic therapy (PDT) due to its negligible photosensitive toxicity. However, the curative effect of 5-ALA is restricted by intracellular biotransformation inactivation of 5-ALA and potential DNA repair of tumor cells. Inspired by the...
Saved in:
Main Authors: | Airong Li (Author), Chenglin Liang (Author), Lihua Xu (Author), Yiyang Wang (Author), Wei Liu (Author), Kaixiang Zhang (Author), Junjie Liu (Author), Jinjin Shi (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Brain metastases: Nanomedicine-boosted diagnosis and treatment
by: Liang Han
Published: (2022) -
Intracellular Reduction-Responsive Molecular Targeted Nanomedicine for Hepatocellular Carcinoma Therapy
by: Lei Ding, et al.
Published: (2022) -
The application of ALA photodynamic fluorescence combined with dermatoscopy in the diagnosis of facial cancerization
by: XIA Liye, et al.
Published: (2024) -
Amplifying the efficacy of ALA-based prodrugs for photodynamic therapy using nanotechnology
by: Liang Lou, et al.
Published: (2023) -
Fusogenic Liposomes for the Intracellular Delivery of Phosphocreatine
by: Okhil K. Nag, et al.
Published: (2024)